| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019112473 |
| P356 | DOI | 10.1007/S11523-016-0437-6 |
| P8608 | Fatcat ID | release_7hs4n5uvrzgzzi65phowlch7rm |
| P698 | PubMed publication ID | 27184491 |
| P50 | author | Silvio Ken Garattini | Q87748439 |
| Nicola Silvestris | Q87916808 | ||
| Francesco Leone | Q88197017 | ||
| Laura Demurtas | Q88349546 | ||
| Riccardo Giampieri | Q91714473 | ||
| Oronzo Brunetti | Q39379387 | ||
| Mario Scartozzi | Q42811548 | ||
| Luca Faloppi | Q55112122 | ||
| Marco Puzzoni | Q57081560 | ||
| Donatella Marino | Q60586248 | ||
| P2093 | author name string | Giuseppe Aprile | |
| Daniele Santini | |||
| Elena Ongaro | |||
| Giorgio Astara | |||
| Laura Orgiano | |||
| Emanuela Dell'Aquila | |||
| P2860 | cites work | The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients | Q87157814 |
| The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients | Q87383239 | ||
| Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 | ||
| Immune Checkpoint Blockade in Cancer Therapy | Q26830509 | ||
| Immunotherapy in gastric cancer | Q27010472 | ||
| Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 | ||
| Cancer immunoediting: from immunosurveillance to tumor escape | Q28212251 | ||
| Comprehensive molecular characterization of gastric adenocarcinoma | Q28244985 | ||
| PD-1 Blockade in Tumors with Mismatch-Repair Deficiency | Q28262647 | ||
| Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma | Q29615443 | ||
| Chronically inflamed livers up-regulate expression of inhibitory B7 family members | Q30434304 | ||
| Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients | Q33552813 | ||
| A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma | Q33579629 | ||
| At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy | Q33732329 | ||
| Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies | Q33895113 | ||
| Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study | Q33937557 | ||
| PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine | Q33950150 | ||
| Effector memory T cells, early metastasis, and survival in colorectal cancer | Q33992461 | ||
| Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial | Q34132937 | ||
| The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis | Q34188723 | ||
| Helicobacter pylori and gastric carcinogenesis. | Q34311677 | ||
| Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients | Q80480802 | ||
| Natural killer cells infiltrating colorectal cancer and MHC class I expression | Q81165432 | ||
| A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma | Q82079122 | ||
| Circulating CD4+CD25+ regulatory T cells in patients with pancreatic cancer | Q82893519 | ||
| Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO | Q83060123 | ||
| Impact of chemotherapy for colorectal cancer on regulatory T-cells and tumor immunity | Q83135484 | ||
| Clinical impact of tumor-infiltrating lymphocytes for survival in curatively resected stage IV colon cancer with isolated liver or lung metastasis | Q85639677 | ||
| A Randomized Trial ofEx vivoCD40L Activation of a Dendritic Cell Vaccine in Colorectal Cancer Patients: Tumor-Specific Immune Responses Are Associated with Improved Survival | Q34365990 | ||
| Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients | Q34450648 | ||
| Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review | Q34551974 | ||
| T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. | Q34621730 | ||
| Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis. | Q34745617 | ||
| The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints | Q34943776 | ||
| Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells | Q34954366 | ||
| Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis | Q35056748 | ||
| VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors | Q35064894 | ||
| Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer. | Q35198371 | ||
| Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. | Q35222367 | ||
| Immunotherapy for hepatocellular carcinoma: From basic research to clinical use. | Q35567765 | ||
| Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention | Q35570715 | ||
| Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation | Q35750826 | ||
| Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity | Q35870655 | ||
| Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy | Q35984560 | ||
| Cytokine-induced killer (CIK) cells: from basic research to clinical translation | Q36121153 | ||
| Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety | Q36444510 | ||
| Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy | Q36464593 | ||
| Natural killer cells as an initial defense against pathogens | Q36502291 | ||
| Cetuximab-mediated tumor regression depends on innate and adaptive immune responses. | Q36512532 | ||
| Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells | Q36539682 | ||
| Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody | Q36544926 | ||
| Cytokine-induced killer cells promote antitumor immunity | Q36741617 | ||
| Molecular and genetic properties of tumors associated with local immune cytolytic activity | Q36869059 | ||
| CD4+CD25+ T regulatory cells and TGF-beta in mucosal immune system: the good and the bad. | Q36952178 | ||
| Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients | Q37068071 | ||
| Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases. | Q37087293 | ||
| Immunotherapeutic approaches to hepatocellular carcinoma treatment | Q37140685 | ||
| Cancer prevention by vaccination against hepatitis B. | Q37391730 | ||
| Immune tolerance: what is unique about the liver | Q37589246 | ||
| Immune response and the tumor microenvironment: how they communicate to regulate gastric cancer | Q37660381 | ||
| Colorectal cancer and immunity: what we know and perspectives | Q37697520 | ||
| The adaptive immune response to colorectal cancer: from the laboratory to clinical practice. | Q38020591 | ||
| Hepatocellualar carcinoma serum markers | Q38030776 | ||
| Systemic therapies in hepatocellular carcinoma: present and future | Q38150875 | ||
| Evolving synergistic combinations of targeted immunotherapies to combat cancer. | Q38553010 | ||
| Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel? | Q38554626 | ||
| Differential induction of apoptosis and senescence by the DNA methyltransferase inhibitors 5-azacytidine and 5-aza-2'-deoxycytidine in solid tumor cells | Q39113815 | ||
| Identification and selective degradation of neopeptide-containing truncated mutant proteins in the tumors with high microsatellite instability | Q39151933 | ||
| The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies | Q39535683 | ||
| Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses | Q39734711 | ||
| Immunogenic death of colon cancer cells treated with oxaliplatin | Q39780621 | ||
| A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma. | Q39922106 | ||
| The concept of immunological surveillance | Q39994321 | ||
| Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation | Q41892760 | ||
| Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection | Q42071282 | ||
| A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C. | Q42989841 | ||
| Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival | Q44332051 | ||
| A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer | Q44370683 | ||
| Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma | Q44517849 | ||
| Prolonged, NK cell-mediated antitumor effects of suicide gene therapy combined with monocyte chemoattractant protein-1 against hepatocellular carcinoma | Q45864615 | ||
| T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer. | Q46973633 | ||
| Chronic inflammation induces a novel epigenetic program that is conserved in intestinal adenomas and in colorectal cancer. | Q50594777 | ||
| Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study. | Q50856082 | ||
| Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy. | Q50965911 | ||
| In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. | Q51889493 | ||
| Dendritic cell infiltration and prognosis of human hepatocellular carcinoma. | Q51985394 | ||
| A meta-analysis of cytokine-induced killer cells therapy in combination with minimally invasive treatment for hepatocellular carcinoma. | Q53042498 | ||
| Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells. | Q53613420 | ||
| Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD. | Q53641367 | ||
| Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer. | Q54494189 | ||
| Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge | Q57079517 | ||
| Radiofrequency Thermal Ablation for Hepatocellular Carcinoma Stimulates Autologous NK-Cell Response | Q58802772 | ||
| Treatment of non-resectable hepatocellular carcinoma with autologous tumor-pulsed dendritic cells | Q74582136 | ||
| Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts | Q77631279 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 593-603 | |
| P577 | publication date | 2016-10-01 | |
| P1433 | published in | Targeted oncology | Q25378200 |
| P1476 | title | The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following? | |
| P478 | volume | 11 |
| Q64093984 | Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment |
| Q39085740 | Determinants of metastatic competency in colorectal cancer |
| Q33779723 | Immunotherapeutic approaches for hepatocellular carcinoma |
| Q64259470 | MHC Class 1 and PDL-1 Status of Primary Tumor and Lymph Node Metastatic Tumor Tissue in Gastric Cancers |
| Q90192336 | RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers |
| Q61448564 | Spontaneous regression of transverse colon cancer with high-frequency microsatellite instability: a case report and literature review |
Search more.